Abstract

Psoriasis is the most common skin disease in adults. Current experimental and clinical evidences suggested the infiltrating immune cells could target local skin cells and thus induce psoriatic phenotype. However, recent studies indicated the existence of a potential feedback signaling loop from local resident skin cells to infiltrating immune cells. Here, we deconstructed the full-thickness human skins of both healthy donors and patients with psoriasis vulgaris at single cell transcriptional level, and further built a neural-network classifier to evaluate the evolutional conservation of skin cell types between mouse and human. Last, we systematically evaluated the intrinsic and intercellular molecular alterations of each cell type between healthy and psoriatic skin. Cross-checking with psoriasis susceptibility gene loci, cell-type based differential expression, and ligand-receptor communication revealed that the resident psoriatic skin cells including mesenchymal and epidermis cell types, which specifically harbored the target genes of psoriasis susceptibility loci, intensively evoked the expression of major histocompatibility complex (MHC) genes, upregulated interferon (INF), tumor necrosis factor (TNF) signalling and increased cytokine gene expression for primarily aiming the neighboring dendritic cells in psoriasis. The comprehensive exploration and pathological observation of psoriasis patient biopsies proposed an uncovered immunoregulatory axis from skin local resident cells to immune cells, thus provided a novel insight for psoriasis treatment. In addition, we published a user-friendly website to exhibit the transcriptional change of each cell type between healthy and psoriatic human skin.

Details

Title
Single cell transcriptional zonation of human psoriasis skin identifies an alternative immunoregulatory axis conducted by skin resident cells
Author
Gao Yuge 1 ; Yao Xinyu 2 ; Zhai Yumeng 3 ; Li, Li 4 ; Li Huini 5 ; Sun Xianqi 3 ; Yu, Pei 3 ; Xue Tiankuo 3 ; Li, Yuzhen 3 ; Hu Yizhou 6   VIAFID ORCID Logo 

 The Second Affiliated Hospital of Harbin Medical University, Department of Dermatology, Harbin, China (GRID:grid.412463.6) (ISNI:0000 0004 1762 6325); University of Helsinki, Institute of Biotechnology, HILIFE Unit, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071) 
 Peking University First Hospital, Department of Dermatology, Beijing, China (GRID:grid.411472.5) (ISNI:0000 0004 1764 1621) 
 The Second Affiliated Hospital of Harbin Medical University, Department of Dermatology, Harbin, China (GRID:grid.412463.6) (ISNI:0000 0004 1762 6325) 
 The Second Affiliated Hospital of Harbin Medical University, Department of Oncology, Harbin, China (GRID:grid.412463.6) (ISNI:0000 0004 1762 6325) 
 University of Helsinki, Institute of Biotechnology, HILIFE Unit, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071) 
 Division of Molecular Neurobiology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Solna, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626) 
Publication year
2021
Publication date
May 2021
Publisher
Springer Nature B.V.
e-ISSN
20414889
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2522497391
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.